[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646773":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":11,"centralContacts":11,"locations":37,"responsibleParty":61,"collaborators":11,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":11,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":11,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":40,"whyStopped":11,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Buddhist Tzu Chi General Hospital","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard Care","ACTIVE_COMPARATOR",null,[13],"Other: Standard Care (in control arm)",{"label":15,"type":16,"description":11,"interventionNames":17},"Standard Care plus Transcutaneous Electrical Nerve Stimulation","EXPERIMENTAL",[13,18],"Device: Transcutaneous Electrical Nerve Stimulation",{"label":20,"type":16,"description":11,"interventionNames":21},"Standard Care plus Transcutaneous Electrical Nerve Stimulation Combined with Far-Infrared Therapy",[13,18,22],"Device: Far-Infrared Therapy",[24,28,33],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"Standard Care (in control arm)","Participants will receive standard care during concurrent chemoradiotherapy according to institutional practice. Standard care includes routine pre-treatment evaluation, radiotherapy followed by chemotherapy, post-radiotherapy cold compresses applied to the irradiated area three times daily, and standard supportive care during chemotherapy.",[9,15,20],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":11},"DEVICE","Transcutaneous Electrical Nerve Stimulation","Participants will receive transcutaneous electrical nerve stimulation twice daily (morning and evening) for five consecutive days during each concurrent chemoradiotherapy cycle. Each treatment session will last 20 minutes. Self-adhesive electrode pads will be applied bilaterally to the Fengchi (GB20), Neiguan (PC6), and Hegu (LI4) acupoints.",[15,20],{"type":29,"name":34,"description":35,"armGroupLabels":36,"otherNames":11},"Far-Infrared Therapy","Participants will receive far-infrared therapy twice daily (morning and evening) for five consecutive days during each concurrent chemoradiotherapy cycle. Each treatment session will last 30 minutes. Participants will be placed in a supine position with the dorsum of both feet exposed. Far-infrared irradiation will be applied bilaterally to the Taichong (LR3) acupoints, with the radiator positioned approximately 20 cm above the treatment sites.",[20],[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","RECRUITING","Hualien City","Hualien County","97002","Taiwan","TW",{"type":47,"coordinates":48},"Point",[49,50],121.60444,23.97694,{"lat":50,"lon":49},[53,58],{"name":54,"role":55,"phone":56,"phoneExt":11,"email":57},"Department of Medical Research","CONTACT","886-3-8561825","hlmweb@tzuchi.com.tw",{"name":59,"role":60,"phone":11,"phoneExt":11,"email":11},"LING-JIE CHEN, BSN","PRINCIPAL_INVESTIGATOR",{"type":62,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100646773","effects-of-far-infrared-rays-and-transcutaneous-electrical-nerve-stimulation-on-short-term-prognosis-of-head-and-neck-cancer-patients-receiving-curative-treatment-100646773",false,"NCT07689019","Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short Term Prognosis of Head and Neck Cancer Patients Receiving Curative Treatment","Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short-Term Prognosis of Head and Neck Cancer Patients Receiving Curative Treatment: A Randomized Controlled Trial","Inclusion Criteria:\n\n1. Adults aged 30 to 85 years.\n2. Histologically confirmed head and neck cancer.\n3. Scheduled to concurrent chemoradiotherapy.\n4. Able to communicate verbally or in writing, willing to complete study questionnaires, and able to comply with all study procedures.\n\nExclusion Criteria:\n\n1. Presence of wounds or skin lesions at the sites where the transcutaneous electrical nerve stimulation electrodes will be applied.\n2. Contraindications to transcutaneous electrical nerve stimulation, including a history of epilepsy, brain tumor, arteriovenous malformation, implanted cardiac pacemaker, or implantable cardioverter-defibrillator, due to the potential risk of electrical stimulation interfering with the underlying medical condition.","ALL","30 Years","85 Years",{"count":74,"type":75},102,"ESTIMATED","INTERVENTIONAL",[78],"NA","This clinical trial aims to evaluate whether far infrared radiation therapy and transcutaneous electrical nerve stimulation can reduce treatment-related side effects in patients with head and neck cancer undergoing concurrent chemoradiotherapy.\n\nThe primary objectives of this study are to determine whether far infrared radiation therapy and transcutaneous electrical nerve stimulation can improve shoulder pain and disability, cervical range of motion, maximum interincisal distance, oral mucositis, systemic inflammation, and chemotherapy-induced nausea and vomiting.\n\nParticipants will be randomly assigned to one of three groups: Group A will receive standard care (control group); Group B will receive standard care plus transcutaneous electrical nerve stimulation; and Group C will receive standard care plus far infrared radiation therapy combined with transcutaneous electrical nerve stimulation.\n\nThe intervention will be administered over two cycles of concurrent chemoradiotherapy, for a total of 10 intervention days. During each treatment cycle, participants in the intervention groups will receive the assigned treatment once every morning and once every evening for five consecutive days. Outcome assessments will be performed at three time points during each treatment cycle: before the intervention on Day 1 (baseline), after the intervention on Day 3, and after the intervention on Day 5.",[81],"Head and Neck Cancer (H&N)",[81,83,84],"transcutaneous electrical nerve stimulation","far infrared","2026-06-30",{"date":87,"type":88},"2026-07-07","ACTUAL",{"date":90,"type":88},"2024-05-15",{"date":92,"type":75},"2026-12-31",{"name":5,"class":6},1]